Study examines the benefit of adding yoga therapy as a complementary treatment for heart failure

Previous studies have shown that yoga therapy and lifestyle modifications have improved heart failure patients’ quality of life and enhanced their cardiovascular function.

What Does FDA Expect from Lykos’ Next Phase 3 MDMA Study? (Part 2) – Psychedelic Alpha

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already

August 28, 2024

Xsolis Leads in Client Satisfaction for Physician Advisory Services

What You Should Know: – A new KLAS Research report examines the key drivers of client satisfaction in the physician advisory services market, highlighting the

November 21, 2024

Allogene’s $110M offering; Apellis refinances

Plus, news about FogPharma, Artbio, Enveric, MindBio and Allozymes: Allogene taps investors for $110M: The biotech priced a common stock offering that included mutual funds,

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.